By my napkin scribbles china is a 6th of the world populous and this 276 million aud in milestone payments now the new benchmark for valuations may mean around 1.6 Billion in similar deals across all regions for just GBM + ongoing royalties.
surely this alone will value us at around 2B in the next two years - plus the value of ongoing royalties - plus the value of other conditions of treatment - plus the 40 million for Cantrixil milestones - plus 12% of Cantrixil sales
tomorrow's price will be interesting but I think we all know it's a minimum x10 from here at some time soon
soon = 2 years or less
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia licenses paxalisib to Simcere in Greater China
Ann: Kazia licenses paxalisib to Simcere in Greater China, page-9
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online